Clinical Trial Details


Back to Clinical Trials Database

Phase III randomized clinical trial in high metastatic risk carcinoma of the prostate comparing pelvic radiotherapy plus LHRH analogue (Jointly with the EORTC Genito-Urinary Cancers Group)

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 01-May-1987
Date Step1 close: 20-Nov-1995
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 300
Study Staff
Type of cancer
Participating groups
Protocol summary
NCT number NCT00849082